InSilico Medicine Cayman TopCo logo

InSilico Medicine Cayman TopCo (3696)

Market Closed
12 Aug, 08:00
HKEX HKEX
45. 92
HKD
-2.08
-4.3333%
HKD
23.03B Market Cap
- P/E Ratio
- Div Yield
10.2M Volume
- Eps
48 HKD
Previous Close
Add Transaction
Day Range
45.68 48.76
Year Range
29.98 80.9
Want to track 3696 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

InSilico Medicine Cayman TopCo (3696) Statistics

Valuation metrics

Market Cap 23.03B
Enterprise value 169.47B
Trailing P/E (ttm) -9.09
Forward P/E -513.49
PEG ratio -513.49
Price/Sales (ttm) 409.56
Price/Book (mrq) 6.33
Enterprise Value/Revenue 384.45
Enterprise Value/EBITDA -377.43

Overview

Shares outstanding 557.42M
Float 438.83M
Shares short -
% Held by insiders 0.33%
% Held by institutions 0.53%
Average volume (10 days) 4.2M
Average volume (90 days) 3.65M

Price summary

52-Week low 29.98
52-Week high 80.9
Beta -
50-Day moving average 58.24
200-Day moving average 58.72

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin 0.82%
Operating margin -1.31%

Operational effectiveness

Return on assets -0.12%
Return on equity -0.78%

Income Statement

Revenue (ttm) 440.8M
Revenue per share (ttm) 0.71
Quarterly revenue growth (yoy) 0.1%
Gross profit (ttm) 359.35M
EBITDA -448.99M
Net income to common (ttm) -2.76B
Diluted EPS (ttm) -35.11
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) 3.51B
Total cash per share (mrq) 0.8
Total debt (mrq) 46.71M
Total Debt/Equity (mrq) 1.32
Current ratio (mrq) 13.99%
Book value per share (mrq) 6.36

Cash Flow

Cash flow statement -601.68M
Levered free cash flow (LFCF) -6.43B